Many lawyers are predicting that the U.S. Department of Justice under Donald Trump will be a pretty business-friendly place, but that doesn’t mean 2017 will be slow in the field of antitrust. Ongoing litigation in industries like pharmaceuticals and banking will continue to keep the antitrust bar busy. Trump might also try to burnish his anti-trade image by cracking down on foreign price-fixing.

Here are five areas to watch:

Pharmaceuticals

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]